Ferring Pharmaceuticals

Company snapshot

Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was

• 2 approved product(s) across US/EU regulatory metadata.
• 13 active pipeline program(s) linked via ClinicalTrials.gov.
• 13 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Ferring Pharmaceuticals. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Ferring Pharmaceuticals.

1. Jun 8, 2026 Clinical update

   REKOVELLE for Idiopathic male infertility (in… — Phase 2

2. Jun 8, 2026 Clinical update

   000426 — Phase 1

3. Jun 8, 2026 Clinical update

   000414 — Phase 1

4. Jun 8, 2026 Clinical update

   TRI-001-01 — Phase 2

5. Jun 8, 2026 Clinical update

   000434 — Phase 3

View all clinical trial activity →

• What is Ferring Pharmaceuticals?

  Ferring Pharmaceuticals is a pharma organization headquartered in Mumbai, IN. Primary therapeutic focus areas include Infertility in women undergoing assisted reproductive technologies (ART), Intermediate risk, non-muscle invasive bladder cancer, Inflammatory Gastrointestinal Dis

• Is Ferring Pharmaceuticals publicly traded?

  Ferring Pharmaceuticals appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Ferring Pharmaceuticals develop or market?

  We link 23 drug profile(s) where Ferring Pharmaceuticals is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s#company-drugs.

• What are the latest developments for Ferring Pharmaceuticals?

  In the last 12 months our linked public records show 13 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Ferring Pharmaceuticals focus on?

  Ferring Pharmaceuticals focuses on Infertility in women undergoing assisted reproductive technologies (ART), Intermediate risk, non-muscle invasive bladder cancer, Inflammatory Gastrointestinal Disease based on our analysis of their pipeline programs and drug development activities.